Inhibitors of prenyl transferases

Said Sebti, Andrew D. Hamilton

Research output: Contribution to journalReview articlepeer-review


Because farnesylation of Ras is required for its cancer-causing activity, several classes of farnesyl transferase inhibitors have recently been developed as potential anticancer drugs. During the last 12 months, important advances have been made in this field. In this review, we focus on three topics: targets of farnesyl transferase inhibitors other than Ras, alternative prenylation of K-Ras by the closely related prenyl transferase, geranyl geranyl transferase I, and the effects of geranyl geranyl transferase I inhibitors on cell cycle, apoptosis, and human tumor growth.

Original languageEnglish (US)
Pages (from-to)557-561
Number of pages5
JournalCurrent Opinion in Oncology
Issue number6
StatePublished - 1997

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Inhibitors of prenyl transferases'. Together they form a unique fingerprint.

Cite this